News Releases

Thermo Fisher Scientific to Present at 36th Annual J.P. Morgan Healthcare Conference on January 9, 2018

WALTHAM, Mass., Jan. 2, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018, at 3:00 p.m. (PST) at the Westin St. Francis, San Francisco, Calif.

 (PRNewsfoto/Thermo Fisher Scientific Inc.)

You can access the live webcast of the presentation in the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Media Contact Information:

Ron O'Brien

Investor Contact Information:

Ken Apicerno

Phone: 781-622-1242

Phone: 781-622-1294

E-mail: ron.obrien@thermofisher.com

E-mail: ken.apicerno@thermofisher.com

Website: www.thermofisher.com


 

SOURCE Thermo Fisher Scientific Inc.